| Identification | Back Directory | [Name]
2-(5,7-DICHLORO-1H-INDOL-3-YL)-ETHYLAMINE HYDROCHLORIDE | [CAS]
94850-28-9 | [Synonyms]
5,7-DichlorotryptaMine HCl
5,7-Dichlorotryptamine hydrochloride
2-(5,7-Dichloro-1H-indol-3-yl)ethanamine hydrochloride
2-(5,7-DICHLORO-1H-INDOL-3-YL)-ETHYLAMINE HYDROCHLORIDE
1H-Indole-3-ethanamine, 5,7-dichloro-, monohydrochloride
2-(5,7-dichloro-1H-indol-3-yl)ethan-1-amine hydrochloride | [Molecular Formula]
C10H11Cl3N2 | [MDL Number]
MFCD00458385 | [MOL File]
94850-28-9.mol | [Molecular Weight]
265.56 |
| Hazard Information | Back Directory | [Description]
5,7-dichloro Tryptamine is a ring-substituted tryptamine derivative. Although the biological effects of this compound have not been reported, tryptamines substituted with fluorine at the 5-, 6-, or 7-position have been shown to have 5-HT2C receptor selectivity over both the 5-HT2A and 5-HT2B subtypes. This product is intended for forensic and research applications. | [References]
[1] ASHER KALIR Stephen S. Synthesis and Pharmacological Activity of Fluorinated Tryptamine Derivatives[J]. Journal of Medicinal Chemistry, 1963, 6 6: 716-719. DOI: 10.1021/jm00342a019
[2] JOSEPH B. BLAIR. Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines[J]. Journal of Medicinal Chemistry, 2000, 43 24: 4701-4710. DOI: 10.1021/jm000339w |
|
| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Website: |
www.bepharm.com |
|